» Authors » Soad A M El-Hawash

Soad A M El-Hawash

Explore the profile of Soad A M El-Hawash including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 110
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
El-Attar M, Elbayaa R, Shaaban O, Habib N, Abdel Wahab A, Abdelwahab I, et al.
Future Med Chem . 2018 Aug; 10(18):2155-2175. PMID: 30088415
Aim: The development of a new class of antimicrobial agents is the optimal lifeline to scrap the escalating jeopardy of drug resistance. Experimental: This study aims to design and synthesize...
2.
El-Attar M, Elbayaa R, Shaaban O, Habib N, Abdel Wahab A, Abdelwahab I, et al.
Bioorg Chem . 2017 Dec; 76:437-448. PMID: 29275262
Development of new antimicrobial agents is a good solution to overcome drug-resistance problems. From this perspective, new quinoxaline derivatives bearing various bioactive heterocyclic moieties (thiadiazoles, oxadiazoles, pyrazoles and thiazoles) were...
3.
El-Miligy M, Hazzaa A, El-Messmary H, Nassra R, M El-Hawash S
Bioorg Chem . 2017 Apr; 72:102-115. PMID: 28390993
New molecular hybrids combining benzothiophene or its bioisostere benzofuran with rhodanine were synthesized as potential dual COX-2/5-LOX inhibitors. The benzothiophene or benzofuran scaffold was linked at position -2 with rhodanine...
4.
Elzahhar P, Soliman R, M El-Hawash S, Ragab H, Youssef A, Abdel Wahab A
Med Chem . 2014 Dec; 11(4):407-14. PMID: 25478930
This work describes the synthesis of new series of compounds derived from methyl pyridyl- 2,4-dioxobutanoates that contain pyridine ring attached to substituted bioactive heterocyclic moieties in order to investigate their...
5.
El-Tombary A, M El-Hawash S
Med Chem . 2013 Oct; 10(5):521-32. PMID: 24151878
The present investigation describes the synthesis of a new series of aldehydo-sugar-N-(3-phenylquinoxalin-2- yl)hydrazones 3a-d and their acyclic C-nucleoside analogs, 1-(4-phenyl-[1,2,4]triazolo[4,3-a]quinoxalin-1-yl)alditols 7ad by using 2-hydrazino-3-phenylquinoxaline 1 as key intermediate. The synthesized...
6.
M El-Hawash S, Soliman R, Youssef A, Ragab H, Elzahhar P, El-Ashmawey I, et al.
Med Chem . 2013 Sep; 10(3):318-38. PMID: 24032466
A series of substituted pyridinylpyrazole (or isoxazole) derivatives were synthesized and evaluated for their anti-inflammatory (AI) activity using formalin-induced paw edema bioassays. Their inhibitory activities of cyclooxygenase-1 and cyclooxygenase-2 (COX-1...
7.
El-Tombary A, M El-Hawash S, Habib N, Soliman R, El-Ashmawy I, Shaaban O
Med Chem . 2013 May; 9(8):1099-112. PMID: 23628080
A novel series of thienopyrimidine derivatives bearing various substituents or linked to various heterocyclic moieties through atoms spacers were prepared starting from 5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6- carboxamide potassium salt 3. Twelve out of...
8.
Rida S, Ashour F, M El-Hawash S, El-Semary M, Badr M
Arch Pharm (Weinheim) . 2007 Mar; 340(4):185-94. PMID: 17351964
In search of novel purine antimetabolites, a series of 8-substituted methylxanthine derivatives was prepared in order to explore their in vitro anticancer, anti-HIV-1 and antimicrobial activities. The target compounds include:...
9.
Rida S, M El-Hawash S, Fahmy H, Hazzaa A, El-Meligy M
Arch Pharm Res . 2006 Nov; 29(10):826-33. PMID: 17121175
Previously, we synthesized and evaluated several benzofuran derivatives containing heterocyclic ring substituents linked to the benzofuran nucleus at C-2 by a two- to four-atom spacer as potential anti-HIV-1, anticancer and...
10.
M El-Hawash S, Habib N, Kassem M
Arch Pharm (Weinheim) . 2006 Sep; 339(10):564-71. PMID: 17009301
Two novel series of quinoxalines derived from 3-phenylquinoxalin-2(1H)-one and 2-hydrazino-3-phenylquinoxaline, namely 1-substituted-3-phenylquinoxaline-2(1H)-ones, 2a-c, 3a-d, and 4; 2-(3-oxo-3,3a,4,5,6,7-hexahydroindazol-2-yl)-3-phenylquinoxaline 6; N- cyclopentylidene or benzylidene-N'-(3-phenylquinoxaline-2-yl)hydrazines, 7 and 18; 1-substituted-4-phenyl-1,2,4-triazolo[4,3-a]quinoxalines, 9, 10, 12, 13,...